Erratum: Steroids and osteoporosis: The quest for mechanisms (Journal of Clinical Investigation (2013) 123, 5 (1919-1921) DOI:10.1172/JCI68062);Steroids and osteoporosis: The quest for mechanisms

Journal of Clinical Investigation

Volumn 123, Issue 5, 2013, Pages 1919-1921

  Manolagas, Stavros C ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BETA CATENIN; CD71 ANTIGEN; ESTROGEN; ESTROGEN RECEPTOR; GLUCOCORTICOID; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN P53; REACTIVE OXYGEN METABOLITE; STEROID HORMONE; TRANSCRIPTION FACTOR FOXO;

AGING; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL SURVIVAL; DISEASE ASSOCIATION; FRACTURE; HOMEOSTASIS; HUMAN; LIFESPAN; MOLECULAR MECHANICS; NONHUMAN; OSTEOCYTE; OSTEOPOROSIS; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; SKELETON;

EID: 84877157804     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI70777     Document Type: Erratum

References (23)

1. Reifenstein EC, Albright F. The metabolic effects of steroid hormones in osteoporosis. J Clin Invest. 1947;26(1):24-56.
2. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp. 1932; 50(5):137-195.
3. Manolagas SC, Anderson DC, Lumb GA. Glucocorticoids regulate the concentration of 1,25-dihydroxycholecalciferol receptors in bone. Nature. 1979; 277(5694):314-315.
4. Eriksen EF, et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 1988; 241(4861):84-86.
5. Komm BS, et al. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science. 1988;241(4861):81-84.
6. Almeida M, et al. Estrogen receptor-alpha signaling in osteoblast progenitors stimulates cortical bone accrual. J Clin Invest. 2013;123(1):394-404.
7. 3 receptors in human leukocytes. Science. 1983;221(4616):1181-1183.
8. 3: a novel immunoregulatory hormone. Science. 1984;224(4656):1438- 1440.
9. Jilka RL, et al. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science. 1992;257(5066):88-91.
10. Bellido T, et al. Regulation of interleukin-6, osteoclastogenesis and bone mass by androgens: the role of the androgen receptor. J Clin Invest. 1995; 95(6):2886-2895.
11. Jilka RL, Takahashi K, Munshi M, Williams DC, Roberson PK, Manolagas SC. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow: evidence for autonomy from factors released during bone resorption. J Clin Invest. 1998;101(9):1942-1950.
12. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998;102(2):274-282.
13. Kousteni S, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 2001;104(5):719-730.
14. Kousteni S, et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 2002;298(5594):843-846.
15. Weinstein RS, et al. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest. 2002;109(8):1041-1048.
16. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest. 1999;104(4):439-446.
17. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21(2):115-137.
18. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA. Matrix-embedded cells control osteoclast formation. Nature Medicine. 2011; 17(10):1235-1241.
19. Manolagas SC, Parfitt AM. For whom the bell tolls: Distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases. Bone. 2012;pii:S8756-3282(12)01246-X.
20. Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010; 31(3):266-300.
21. Almeida M, Han L, Ambrogini E, Bartell SM, Manolagas SC. Oxidative stress stimulates apoptosis and activates NF-kappaB in osteoblastic cells via a PKCbeta/p66shc signaling cascade: counter regulation by estrogens or androgens. Mol Endocrinol. 2010;24(10):2030-2037.
22. Almeida M, Han L, Ambrogini E, Weinstein RS, Manolagas SC. Glucocorticoids and tumor necrosis factor (TNF) alpha increase oxidative stress and suppress WNT signaling in osteoblasts. J Biol Chem. 2011;286(52):44326- 44335.
23. Weinstein RS, et al. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell. 2010; 9(2):147-161.